Progyny(PGNY) - 2023 Q4 - Annual Results

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% Growth Achieves 49% Growth in Adjusted EBITDA to Record$ 187.1 Million Issues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint NEW YORK, February 27, 2024 /GlobeNewswire/ - Progyny, Inc. (Nasdaq: PGNY) ("Progyny" or the "Company"), a transformative fertility, family building and women's health benefits solution, today announced its financial results for the three- and twelve-month periods ended December 31, 2023 ...